NiveshIQNiveshIQ
NSE: YATHARTH  ·  Healthcare

Yatharth Hospital & Trauma Care Services Ltd.

₹832.90▼ ₹1.05 (-0.13%)
Volume: 105,535Day Range: ₹830.20 – ₹844.8052W Range: ₹538.25 – ₹889.90
Price Chart  ·  Daily closes
1Y 6M 3M 1M 1W 1D
⚡ Intelligence Signals 5 active
🟢 Bullish Earnings Catalyst 📊 RS Laggard (5D) 🔄 Sector Sweep ⚡ Signals Aligned 📉 Pullback

NiveshIQ has detected 5 active signals on YATHARTH. Sign up free to see what each signal means and how it affects the stock.

Unlock signals — free
Expected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74 / 100

About Yatharth Hospital & Trauma Care Services Ltd.

Yatharth Hospital & Trauma Care Services Limited is a leading healthcare provider in India, operating super-specialty hospitals across the country. The company offers a wide range of medical services, including cardiology, neurosciences, general surgery, and more, with a focus on providing high-quality patient care. With a strong presence in the Indian healthcare market, Yatharth Hospital has established itself as a trusted brand, attracting a large patient base. The company's diversified service offerings, including medicine sales and canteen food, contribute significantly to its revenue. In FY26, the promoters confirmed no share encumbrance, indicating a strong financial position. Yatharth Hospital's growth outlook is promising, driven by increasing demand for quality healthcare services

Financial Highlights

MetricFY24FY25FY26
Revenue₹635.00 Cr +32.80%₹860.00 Cr +35.40%₹1,207 Cr +40.40%
EBITDA Margin28.66%26.16%26.33%
Net Profit₹114.00 Cr +72.70%₹131.00 Cr +14.90%₹170.30 Cr +30.00%
EPS₹13.33₹13.55₹18.20

Annual figures in Indian Rupees (Crores). Source: BSE filings.

Analyst ConsensusConsensus target ₹986.00  |  Buy 4 · Hold 0 · Sell 0Sign in to see →

Recent News

🔒
+ 3 more stories about Yatharth Hospital & Trauma Care Services Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instant

Strategic Outlook

Management commentary highlights order wins, deal pipeline, and backlog build as key near-term growth drivers, with exec...

FY26 (last completed FY): revenue ₹1, 207 Cr, PAT ₹170 Cr, EBITDA margin 26.3%, EPS ₹18.20. Year-on-year: revenue YoY +4...

🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instant

Everything you unlock with a free account

Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for YATHARTH
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track YATHARTH alongside your other holdings
Unlock full YATHARTH research — free
No credit card  ·  No trial  ·  Always free to start

Frequently Asked Questions

What AI signals does NiveshIQ provide for Yatharth Hospital & Trauma Care Services Ltd.?

NiveshIQ detects active intelligence signals for Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.

What are the key financials for Yatharth Hospital & Trauma Care Services Ltd.?

Yatharth Hospital & Trauma Care Services Ltd. operates in the Healthcare sector with a market capitalisation of ₹830,574.6L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.

Does NiveshIQ provide investment advice?

No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.

Viewing preview of Yatharth Hospital & Trauma Care Services Ltd. — 5 active signals detected Unlock full analysis — free